| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:07:59 -0700 |
| HMDB ID |
HMDB00149 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Ethanolamine |
| Description |
Ethanolamine is a viscous, hygroscopic amino alcohol with an ammoniacal odor. It is widely distributed in biological tissue and is a component of lecithin. It is used as a surfactant, fluorometric reagent, and to remove CO2 and H2S from natural gas and other gases. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 1-Amino-2-hydroxyethane
- 2-Amino-1-ethanol
- 2-Aminoethanol
- 2-Aminoethyl alcohol
- 2-Ethanolamine
- 2-Hydroxyethanamine
- 2-Hydroxyethylamine
- Aethanolamin
- Aminoethanol
- b-Aminoethanol
- b-Aminoethyl alcohol
- b-Ethanolamine
- b-Hydroxyethylamine
- beta-Aminoethanol
- beta-Aminoethyl alcohol
- beta-Ethanolamine
- beta-Hydroxyethylamine
- Colamine
- Envision Conditioner PDD 9020
- eta
- Ethanolamine
- Ethylolamine
- Glycinol
- H-Glycinol
- MEA
- Monoaethanolamin
- Monoethanolamine
- Olamine
|
| Chemical Formula |
C2H7NO |
| Average Molecular Weight |
61.0831 |
| Monoisotopic Molecular Weight |
61.052763851 |
| IUPAC Name |
2-aminoethan-1-ol |
| Traditional IUPAC Name |
ethanolamine |
| CAS Registry Number |
141-43-5 |
| SMILES |
NCCO |
| InChI Identifier |
InChI=1S/C2H7NO/c3-1-2-4/h4H,1-3H2 |
| InChI Key |
HZAXFHJVJLSVMW-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aliphatic Acyclic Compounds |
| Class |
Alkylamines |
| Sub Class |
1,2-Aminoalcohols |
| Other Descriptors |
- Alkylamines
- Biogenic amines(KEGG)
- ethanolamines(ChEBI)
|
| Substituents |
|
| Direct Parent |
1,2-Aminoalcohols |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Glycerophospholipid metabolism
|
| Application |
Not Available |
| Cellular locations |
|
| Physical Properties |
| State |
Liquid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
10.5 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
1000.0 mg/mL |
Not Available |
| LogP |
-1.31 |
HANSCH,C ET AL. (1995) |
|
| Predicted Properties |
|
| Spectra |
|
| Gas-MS Spectrum |
| 1H NMR Spectrum |
| 13C NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum EI-B (HITACHI RMU-7M) |
| MS/MS Spectrum EI-B (HITACHI M-68) |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50 |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies ) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| MS/MS Spectrum GC-MS |
| [1H,1H] 2D NMR Spectrum |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
- Most Tissues
- Pancreas
- Epidermis
- Brain
- Myelin
- Nerve Cells
- Stratum Corneum
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
52.3 (26.2-91.7) uM |
Newborn (0-30 days old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
1.6 (0.0-11.5) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
14.1 +/- 3.0 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
8.43 (2.62-14.24) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
30.9 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
4.91-24.57 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.0028 - 0.0087 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
42.75 umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
37.1 (24.8-56.2) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
urine by NMR
|
| Urine |
Detected and Quantified |
|
29.5 +/- 7.8 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Urine |
Detected and Quantified |
|
0.0028 - 0.0087 umol/mmol creatinine |
Adult (>18 years old) |
Both |
ADPKD |
Not Available |
| Urine |
Detected and Quantified |
|
31.7 +/- 6.5 umol/mmol creatinine |
Adult (>18 years old) |
Both |
3-Hydroxy-3- methylglutaryl-CoA lyase (HL) deficency |
Not Available |
| Urine |
Detected and Quantified |
|
39.7 +/- 0 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Propionic acidemia |
Not Available |
| Urine |
Detected and Quantified |
|
99.7 +/- 3.3 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Maple syrup urine disease |
Not Available |
| Urine |
Detected and Quantified |
|
51.9 +/- 0 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Aminoaciduria |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
DB03994  |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB000769 |
| KNApSAcK ID |
C00007279  |
| Chemspider ID |
13835336  |
| KEGG Compound ID |
C00189  |
| BioCyc ID |
ETHANOL-AMINE  |
| BiGG ID |
34189  |
| Wikipedia Link |
Ethanolamine  |
| NuGOwiki Link |
HMDB00149  |
| Metagene Link |
HMDB00149  |
| METLIN ID |
3207  |
| PubChem Compound |
700  |
| PDB ID |
ETA  |
| ChEBI ID |
16000  |
| References |
| Synthesis Reference |
Soucaille, Philippe. Ethanolamine production by fermentation of genetically modified Escherichia coli. PCT Int. Appl. (2007), 23pp. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Denissen JF, Grabowski BA, Johnson MK, Boyd SA, Uchic JT, Stein H, Cepa S, Hill P: The orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans. Drug Metab Dispos. 1994 Nov-Dec;22(6):880-8.
Pubmed: 7895605
- Vance JE: Lipoproteins secreted by cultured rat hepatocytes contain the antioxidant 1-alk-1-enyl-2-acylglycerophosphoethanolamine. Biochim Biophys Acta. 1990 Jul 16;1045(2):128-34.
Pubmed: 2116174
- Alberghina M, Giacchetto A, Cavallaro N: Levels of ethanolamine intermediates in the human and rat visual system structures: comparison with neural tissues of a lower vertebrate (Mustelus canis) and an invertebrate (Loligo pealei). Neurochem Int. 1993 Jan;22(1):45-51.
Pubmed: 8443564
- Hammond EJ, Uthman BM, Wilder BJ, Ben-Menachem E, Hamberger A, Hedner T, Ekman R: Neurochemical effects of vagus nerve stimulation in humans. Brain Res. 1992 Jun 26;583(1-2):300-3.
Pubmed: 1504837
- Perschak H, Amsler U, Vischer A, Siegfried J, Cuenod M: Ventricular cerebrospinal fluid concentrations of putative amino acid transmitters in Parkinson's disease and other disorders. Hum Neurobiol. 1987;6(3):191-4.
Pubmed: 2896652
- Renkonen O: Chromatographic separation of plasmalogenic, alkyl-acyl, and diacyl forms of ethanolamine glycerophosphatides. J Lipid Res. 1968 Jan;9(1):34-9.
Pubmed: 4295349
- Ginsberg L, Rafique S, Xuereb JH, Rapoport SI, Gershfeld NL: Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res. 1995 Nov 6;698(1-2):223-6.
Pubmed: 8581486
- Bluml S, Seymour KJ, Ross BD: Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain. Magn Reson Med. 1999 Oct;42(4):643-54.
Pubmed: 10502752
- Farooqui AA, Rapoport SI, Horrocks LA: Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens. Neurochem Res. 1997 Apr;22(4):523-7.
Pubmed: 9130265
- Mikhaevich IS, Vlasenkova NK, Gerasimova GK: Synergistic antiproliferative effect of cis-diammine-dichloroplatinum (II) and a new anticancer agent, plasmanyl-(N-acyl)-ethanolamine, an inhibitor of protein kinase C. Biomed Sci. 1991;2(6):659-64.
Pubmed: 1841636
- Engelborghs S, Marescau B, De Deyn PP: Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease. Neurochem Res. 2003 Aug;28(8):1145-50.
Pubmed: 12834252
|
| Enzymes |
| Name: |
Phospholipase D2
|
| Reactions: |
- a phosphatidylcholine + H2O = choline + a phosphatidate [RN:R01310]
|
| Gene Name: |
PLD2 |
| Uniprot ID: |
O14939  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|